More on anti-glomerular basement membrane disease after alemtuzumab.
Shin
Jae Il
JI
Lee
Jae Seung
JS
D000074323:Alemtuzumab; D000818:Animals; D019867:Anti-Glomerular Basement Membrane Disease / Q000139:chemically induced* / Q000276:immunology; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000912:Antibodies, Neoplasm / Q000009:adverse effects*; D001323:Autoantibodies; D015551:Autoimmunity; D001402:B-Lymphocytes; D018414:CD8-Positive T-Lymphocytes; D006801:Humans; D018655:Lymphocyte Count
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000912:Antibodies, Neoplasm; D001323:Autoantibodies; D000074323:Alemtuzumab